Verve Therapeutics, Inc. (VERV)
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Address
201 BROOKLINE AVENUE
BOSTON, MA 02215
Founded
2018
Number of Employees
255
Website
http://www.vervetx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)